The functional impact of KRAS mutations in CRC depends on the specific amino acid substitution, as different mutations result in distinct biochemical and signaling alterations that influence tumor behaviors and therapeutic responses [40]. The gene discussed is KRAS; the disease is colorectal carcinoma.